--- title: "IRADIMED CORP (IRMD) stock: news and investor profile" url: "https://aibio.space/companies/iradimed/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "IRADIMED CORP (NASDAQ: IRMD), United States. Listing facts, related biotech companies and news on aibio.space." --- IRMD IRADIMED CORP NASDAQ · United States # IRADIMED CORP (IRMD) news IRADIMED CORP is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IRMD, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest IRADIMED CORP news We have not published a story on IRADIMED CORP yet. When there is news, it will appear here. ## IRADIMED CORP at a glance - **Ticker**: IRMD - **Listing**: NASDAQ - **Country**: United States - **Cash, Sep 30, 2026**: $63.3 million ### Related companies - [VERACYTE, INC.](https://aibio.space/companies/veracyte/) NASDAQ: VCYT - [NeuroPace](https://aibio.space/companies/neuropace/) NASDAQ: NPCE - [BIOADAPTIVES, INC.](https://aibio.space/companies/bioadaptives/) OTC: BDPT - [enVVeno Medical](https://aibio.space/companies/envveno-medical/) NASDAQ: NVNO - [AIBOTICS, INC.](https://aibio.space/companies/aibotics/) OTC: AIBT - [IQVIA HOLDINGS INC.](https://aibio.space/companies/iqvia/) NYSE: IQV - [ALR Technologies SG](https://aibio.space/companies/alr-technologies-sg/) OTC: ALRTF - [Twist Bioscience](https://aibio.space/companies/twist-bioscience/) NASDAQ: TWST ### Also on NASDAQ - [Korsana Biosciences](https://aibio.space/companies/korsana-biosciences/) KRSA - [Akebia Therapeutics](https://aibio.space/companies/akebia-therapeutics/) AKBA - [BeyondSpring](https://aibio.space/companies/beyondspring/) BYSI - [Caribou Biosciences](https://aibio.space/companies/caribou-biosciences/) CRBU - [Neuphoria Therapeutics](https://aibio.space/companies/neuphoria-therapeutics/) NEUP - [Editas Medicine](https://aibio.space/companies/editas-medicine/) EDIT ## IRADIMED CORP annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$83.8 million](https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/) | [$73.2 million](https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/) | | Research and development | [$3.0 million](https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/) | [$2.8 million](https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/) | | Net income (loss) | [$22.5 million](https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/) | [$19.2 million](https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/) | | Cash from operations | [$24.9 million](https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/) | [$25.6 million](https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/) | | Cash and equivalents | [$51.2 million](https://www.sec.gov/Archives/edgar/data/1325618/000162828026068576/) | [$52.2 million](https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/) | Latest balance sheet, Sep 30, 2026 (10-Q): cash and equivalents $63.3 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about IRADIMED CORP What is the ticker symbol of IRADIMED CORP? IRADIMED CORP trades under the ticker IRMD on NASDAQ. Where is IRADIMED CORP listed? IRADIMED CORP is listed on NASDAQ. Which country or territory is IRADIMED CORP listed under? Our directory records IRADIMED CORP under United States. Does aibio.space cover IRADIMED CORP? aibio.space lists IRADIMED CORP among 2,820 public biotech companies and publishes its news here as stories appear. What was IRADIMED CORP's revenue last year? $83.8 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is IRADIMED CORP profitable? IRADIMED CORP reported net income of $22.5 million for the fiscal year ended Dec 31, 2025, and generated $24.9 million of cash from operations, per its annual report to the SEC. How much does IRADIMED CORP spend on research and development? $3.0 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does IRADIMED CORP have? $63.3 million in cash at Sep 30, 2026, per its 10-Q. ## Investor discussion: IRADIMED CORP Members talk about IRADIMED CORP (IRMD). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:IRMD on TradingView](https://www.tradingview.com/symbols/NASDAQ-IRMD/). ## Listing details IRADIMED CORP is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IRMD, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: IRADIMED CORP - **Ticker**: IRMD - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/iradimed/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "IRADIMED CORP (IRMD) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/iradimed/